EUVIMEDEUVIMED entdecken
BeobachtungsstudieÜbersichtsarbeitOpen Access · CC BY 4.0

Outcomes of patients with clinical stage IV esophageal squamous cell carcinoma treated initially with definitive chemoradiotherapy: a single-institution observational study and literature review

Kotaro Sugawara, Koichi Yagi, Shoh Yajima, Yoshiyuki Miwa, Shuichiro Oya, Asami Okamoto, Raito Asaoka, Hideomi Yamashita, Yoshifumi Baba

Surgery Today · 2025

DOI: 10.1007/s00595-025-03087-x ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Surgery Today, 2025. Verfasst von Kotaro Sugawara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan. mayotic…. Hauptthemen laut MEDLINE: Chemoradiotherapy, Esophageal Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Tokyo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate the long-term outcomes of patients with cStage IV esophageal squamous cell carcinoma (ESCC) treated with definitive chemoradiotherapy (dCRT) and the impacts of this treatment on inflammatory and nutrition markers.

Methods

The subjects of this study were 84 patients who underwent initial dCRT for cStage IV (cT4 and/or cM1 according to eighth UICC staging system) esophageal squamous cell carcinoma (ESCC). Survival outcomes were investigated according to treatment modalities. Various inflammatory and nutrition markers, such as the C-reactive protein (CRP)-to-albumin ratio (CAR) and the lymphocyte-to-CRP ratio (LCR), were evaluated.

Results

The 3-year overall survival (OS) rate of the 84 patients was 45.8%. Clinical complete response (CR) to dCRT was achieved in 30 patients (dCRT-CR group). Salvage surgery was performed for 35 patients and curative (R0) resection was achieved in 28 patients (surg-R0 group). Patients in the surg-R0 group exhibited comparable 3-year OS (60.7%) to patients in the dCRT-CR group (60.0%). CRP-derived markers (LCR and CAR) were significantly associated with the response to dCRT (both P < 0.01) and OS (both P < 0.01).

Conclusions

Definitive chemoradiotherapy is appropriate for patients with cStage IV ESCC. Curative salvage surgery provides survival benefits for the tumor entity. Pre-therapeutic CRP-derived markers are useful for predicting the response to dCRT and long-term outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChemoradiotherapyEsophageal NeoplasmsCarcinoma, Squamous CellHumansMaleFemaleNeoplasm StagingMiddle AgedAgedTreatment OutcomeC-Reactive ProteinSurvival RateEsophageal Squamous Cell CarcinomaBiomarkers, TumorTime FactorsSalvage TherapyAdultAged, 80 and overBiomarkers

Stichwörter der Autor:innen

Clinical stage IVDefinitive chemoradiotherapyEsophageal squamous cell carcinomaSalvage surgery

Substanzen

C-Reactive ProteinBiomarkers, TumorBiomarkers

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan. mayotic@hotmail.com.
  • Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo, 113-8655, Japan.
  • Department of Radiology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

Förderung

  • The University of Tokyo

Zitieren

APA

Sugawara, K., Yagi, K., Yajima, S., Miwa, Y., Oya, S., Okamoto, A., Asaoka, R., Yamashita, H., & Baba, Y. (2025). Outcomes of patients with clinical stage IV esophageal squamous cell carcinoma treated initially with definitive chemoradiotherapy: a single-institution observational study and literature review. Surgery Today. https://doi.org/10.1007/s00595-025-03087-x

Vancouver

Sugawara K, Yagi K, Yajima S, Miwa Y, Oya S, Okamoto A, et al. Outcomes of patients with clinical stage IV esophageal squamous cell carcinoma treated initially with definitive chemoradiotherapy: a single-institution observational study and literature review. Surgery Today. 2025. doi:10.1007/s00595-025-03087-x

BibTeX
@article{Sugawara2025,
  author = {Sugawara, Kotaro and Yagi, Koichi and Yajima, Shoh and Miwa, Yoshiyuki and Oya, Shuichiro and Okamoto, Asami and Asaoka, Raito and Yamashita, Hideomi and Baba, Yoshifumi},
  title = {Outcomes of patients with clinical stage IV esophageal squamous cell carcinoma treated initially with definitive chemoradiotherapy: a single-institution observational study and literature review},
  journal = {Surgery Today},
  year = {2025},
  doi = {10.1007/s00595-025-03087-x}
}
Kostenlos starten →